Stephan Heckers, M.D., M.Sc., William P. and Henry B. Test Professor of Schizophrenia Research and chair of the Department of Psychiatry, has been named the next editor-in-chief of JAMA Psychiatry, one of nine specialty journals in the JAMA Network.

It may be possible to use skin cells as biomarkers to diagnose and manage depression.

A retrospective analysis of Tennessee physicians who underwent fitness-for-duty evaluations by Vanderbilt found an “astoundingly” high rate of suicide among physicians who were found unfit to practice, were in solo practice, or if they were taking anti-anxiety drugs.

Vanderbilt investigators have constructed a network map that could guide the development of new targeted cancer therapies.

Augmenting the signals of natural “endocannabinoids” in the brain may be a promising approach for treating mood and anxiety disorders.

Vanderbilt investigators have used two types of neuroimaging to establish a “map” of connections for a brain region important in anxiety and addiction.

Researchers at Vanderbilt have been able to alter mouse behavior by silencing gene expression in interneurons, distinct populations of nerve cells that are the main regulators of brain circuits.